Analyzing Moolec Science (MLEC) & The Competition

Moolec Science (NASDAQ:MLEC) is one of 665 public companies in the “Holding & other investment offices” industry, but how does it compare to its competitors? We will compare Moolec Science to similar businesses based on the strength of its institutional ownership, risk, profitability, dividends, analyst recommendations, valuation and earnings.

Valuation & Earnings

This table compares Moolec Science and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Moolec Science	$5.62 million	-$7.31 million	-4.45
Moolec Science Competitors	$972.79 million	$78.18 million	51.03

Moolec Science’s competitors have higher revenue and earnings than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Moolec Science and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	-129.97%	-93.88%	-33.37%
Moolec Science Competitors	-17.70%	-42.87%	-0.63%

Volatility and Risk

Moolec Science has a beta of -0.54, indicating that its share price is 154% less volatile than the S&P 500. Comparatively, Moolec Science’s competitors have a beta of 0.03, indicating that their average share price is 97% less volatile than the S&P 500.

Institutional and Insider Ownership

0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 54.1% of shares of all “Holding & other investment offices” companies are owned by institutional investors. 19.9% of Moolec Science shares are owned by insiders. Comparatively, 26.3% of shares of all “Holding & other investment offices” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for Moolec Science and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	1	0	3.00
Moolec Science Competitors	128	728	960	19	2.47

Moolec Science currently has a consensus target price of $6.00, indicating a potential upside of 574.23%. As a group, “Holding & other investment offices” companies have a potential upside of 54.61%. Given Moolec Science’s stronger consensus rating and higher probable upside, research analysts clearly believe Moolec Science is more favorable than its competitors.

Summary

Moolec Science competitors beat Moolec Science on 10 of the 13 factors compared.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.